ISRG vs JPM: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and JPMorgan Chase & Co. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-16.
Intuitive Surgical, Inc. · Healthcare
$388.97
+45.0% upside to fair value
Grade B
High Quality
VS
JPMorgan Chase & Co. · Financial Services
$334.53
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
JPM trades at a lower forward P/E
(14.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ISRG |
JPM |
| Current Price |
$388.97 |
$334.53 |
| Fair Value Estimate |
$564.01 |
$485.07 |
| Upside to Fair Value |
+45.0%
|
+45.0%
|
| Market Cap |
$137.8B |
$896.4B |
| Forward P/E |
46.5x
|
14.3x
|
| EV / EBITDA |
31.4x
|
12.4x
|
| Price / Sales |
13.0x
|
5.4x
|
| Price / FCF |
48.6x
|
6.4x
|
| Revenue Growth YoY |
+23.0%
|
-168.4%
|
| Gross Margin |
66.3%
|
78.6%
|
| Operating Margin |
30.5%
|
33.7%
|
| Return on Equity |
17.0%
|
17.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.06%
|
15.72%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Intuitive Surgical, Inc. operates in the healthcare sector, specializing in medical devices with a strong focus on robotic-assisted surgery systems. The company demonstrates high business quality with a durable competitive moat supported by a 17.0% return on equity, robust gross margin of 66.3%, and solid operating margin of 30.5%. Revenue and earnings growth in the most recent quarter were impre…
JPMorgan Chase & Co. operates as a leading diversified bank within the financial services sector, demonstrating a high-quality business model characterized by a strong return on equity of 17.8% and robust profitability margins including a net margin of 38.9%. Despite a significant revenue decline of 168.4% year-over-year in the most recent quarter, earnings grew by 41.2%, reflecting operational e…
Accumulation Zones
| Metric |
ISRG |
JPM |
| Zone Low |
$423.01 |
$363.80 |
| Zone High |
$479.41 |
$412.31 |
| In Buy Zone? |
Yes
|
Yes
|